Engineers Gate Manager LP Merck & Co., Inc. Transaction History

Engineers Gate Manager LP

  • $8.12 Billion
  • Q3 2025

A detailed history of Engineers Gate Manager LP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 81,262 shares of MRK stock, worth $7.55 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
81,262
Previous 2,622 2999.24%
Holding current value
$7.55 Million
Previous $207,000 3194.69%
% of portfolio
0.08%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
$77.6 - $87.37 $6.1 Million - $6.87 Million
78,640 Added 2999.24%
81,262 $6.82 Million
Q2 2025

Aug 14, 2025
SELL
$73.47 - $87.12 $16.2 Million - $19.2 Million
-220,342 Reduced 98.82%
2,622 $207,000
Q1 2025

May 15, 2025
BUY
$83.01 - $101.02 $12.7 Million - $15.4 Million
152,393 Added 215.94%
222,964 $20 Million
Q4 2024

Feb 14, 2025
SELL
$96.31 - $114.76 $1.36 Million - $1.62 Million
-14,129 Reduced 16.68%
70,571 $7.02 Million
Q3 2024

Nov 14, 2024
SELL
$111.15 - $128.97 $8.34 Million - $9.68 Million
-75,050 Reduced 46.98%
84,700 $9.62 Million
Q2 2024

Aug 14, 2024
BUY
$123.8 - $132.96 $18.4 Million - $19.8 Million
148,648 Added 1338.93%
159,750 $19.8 Million
Q1 2024

May 15, 2024
SELL
$113.24 - $131.95 $1.12 Million - $1.31 Million
-9,921 Reduced 47.19%
11,102 $1.46 Million
Q4 2023

Feb 14, 2024
SELL
$100.18 - $109.02 $6.51 Million - $7.08 Million
-64,938 Reduced 75.54%
21,023 $2.29 Million
Q3 2023

Nov 14, 2023
BUY
$102.95 - $114.33 $8.85 Million - $9.83 Million
85,961 New
85,961 $8.85 Million
Q3 2022

Nov 14, 2022
BUY
$84.53 - $94.96 $159,000 - $178,619
1,881 Added 54.66%
5,322 $458,000
Q2 2022

Aug 15, 2022
SELL
$83.49 - $94.64 $839,408 - $951,510
-10,054 Reduced 74.5%
3,441 $314,000
Q1 2022

May 16, 2022
SELL
$73.51 - $82.4 $2.36 Million - $2.65 Million
-32,152 Reduced 70.44%
13,495 $1.11 Million
Q4 2021

Feb 14, 2022
BUY
$72.28 - $90.54 $1.71 Million - $2.14 Million
23,613 Added 107.17%
45,647 $3.5 Million
Q3 2021

Nov 15, 2021
BUY
$71.68 - $78.83 $1.58 Million - $1.74 Million
22,034 New
22,034 $1.66 Million
Q2 2021

Aug 16, 2021
SELL
$70.31 - $77.77 $721,169 - $797,686
-10,257 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$68.86 - $81.11 $8.29 Million - $9.76 Million
-120,387 Reduced 92.15%
10,257 $791,000
Q4 2020

Feb 16, 2021
BUY
$71.77 - $79.65 $6.05 Million - $6.71 Million
84,305 Added 181.93%
130,644 $10.7 Million
Q3 2020

Nov 16, 2020
SELL
$73.18 - $82.95 $3.45 Million - $3.91 Million
-47,188 Reduced 50.45%
46,339 $3.84 Million
Q2 2020

Aug 17, 2020
BUY
$70.42 - $80.13 $5.19 Million - $5.91 Million
73,763 Added 373.22%
93,527 $7.23 Million
Q1 2020

May 15, 2020
BUY
$63.36 - $87.82 $536,469 - $743,571
8,467 Added 74.95%
19,764 $1.52 Million
Q4 2019

Feb 14, 2020
SELL
$77.58 - $87.54 $279,132 - $314,968
-3,598 Reduced 24.16%
11,297 $1.03 Million
Q3 2019

Nov 14, 2019
BUY
$76.08 - $82.93 $656,874 - $716,017
8,634 Added 137.9%
14,895 $1.25 Million
Q2 2019

Aug 14, 2019
BUY
$69.84 - $81.59 $227,748 - $266,064
3,261 Added 108.7%
6,261 $525,000
Q1 2019

May 15, 2019
BUY
$69.58 - $79.36 $208,740 - $238,080
3,000 New
3,000 $250,000
Q2 2018

Aug 03, 2018
SELL
$50.83 - $59.72 $6.63 Million - $7.79 Million
-130,454 Closed
0 $0
Q1 2018

May 07, 2018
BUY
$50.96 - $59.23 $5.62 Million - $6.53 Million
110,332 Added 548.32%
130,454 $7.11 Million
Q4 2017

Feb 01, 2018
BUY
$51.62 - $61.64 $641,584 - $766,123
12,429 Added 161.56%
20,122 $1.13 Million
Q3 2017

Nov 13, 2017
BUY
$58.67 - $63.13 $451,348 - $485,659
7,693
7,693 $493,000

Others Institutions Holding MRK

# of Institutions
3,878
Shares Held
1.9B
Call Options Held
30.1M
Put Options Held
27.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $235B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Engineers Gate Manager LP Portfolio

Follow Engineers Gate Manager LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email